146 related articles for article (PubMed ID: 14609213)
1. CD4+CD25+ regulatory cells from human peripheral blood express very high levels of CD25 ex vivo.
Baecher-Allan C; Brown JA; Freeman GJ; Hafler DA
Novartis Found Symp; 2003; 252():67-88; discussion 88-91, 106-14. PubMed ID: 14609213
[TBL] [Abstract][Full Text] [Related]
2. CD4+CD25high regulatory cells in human peripheral blood.
Baecher-Allan C; Brown JA; Freeman GJ; Hafler DA
J Immunol; 2001 Aug; 167(3):1245-53. PubMed ID: 11466340
[TBL] [Abstract][Full Text] [Related]
3. Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells.
Hoffmann P; Eder R; Kunz-Schughart LA; Andreesen R; Edinger M
Blood; 2004 Aug; 104(3):895-903. PubMed ID: 15090447
[TBL] [Abstract][Full Text] [Related]
4. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity.
Tsaknaridis L; Spencer L; Culbertson N; Hicks K; LaTocha D; Chou YK; Whitham RH; Bakke A; Jones RE; Offner H; Bourdette DN; Vandenbark AA
J Neurosci Res; 2003 Oct; 74(2):296-308. PubMed ID: 14515359
[TBL] [Abstract][Full Text] [Related]
5. CD25+CD4+ T cells in human cord blood: an immunoregulatory subset with naive phenotype and specific expression of forkhead box p3 (Foxp3) gene.
Takahata Y; Nomura A; Takada H; Ohga S; Furuno K; Hikino S; Nakayama H; Sakaguchi S; Hara T
Exp Hematol; 2004 Jul; 32(7):622-9. PubMed ID: 15246158
[TBL] [Abstract][Full Text] [Related]
6. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta.
Nakamura K; Kitani A; Strober W
J Exp Med; 2001 Sep; 194(5):629-44. PubMed ID: 11535631
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+ CD25+ T cells.
Baecher-Allan C; Wolf E; Hafler DA
Clin Immunol; 2005 Apr; 115(1):10-8. PubMed ID: 15870015
[TBL] [Abstract][Full Text] [Related]
8. A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood.
Yamagiwa S; Gray JD; Hashimoto S; Horwitz DA
J Immunol; 2001 Jun; 166(12):7282-9. PubMed ID: 11390478
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of inhibitory effect of intravenous immunoglobulin on neonatal umbilical cord blood lymphocytes].
Hao YQ; Chen TX; Zhu YZ; Li QS
Zhonghua Er Ke Za Zhi; 2005 Jun; 43(6):438-43. PubMed ID: 16053731
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
11. Acquisition of anergic and suppressive activities in transforming growth factor-beta-costimulated CD4+CD25- T cells.
Park HB; Paik DJ; Jang E; Hong S; Youn J
Int Immunol; 2004 Aug; 16(8):1203-13. PubMed ID: 15237111
[TBL] [Abstract][Full Text] [Related]
12. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro.
Stephens LA; Mottet C; Mason D; Powrie F
Eur J Immunol; 2001 Apr; 31(4):1247-54. PubMed ID: 11298351
[TBL] [Abstract][Full Text] [Related]
13. The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age.
Gregg R; Smith CM; Clark FJ; Dunnion D; Khan N; Chakraverty R; Nayak L; Moss PA
Clin Exp Immunol; 2005 Jun; 140(3):540-6. PubMed ID: 15932517
[TBL] [Abstract][Full Text] [Related]
14. Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population.
Taams LS; Smith J; Rustin MH; Salmon M; Poulter LW; Akbar AN
Eur J Immunol; 2001 Apr; 31(4):1122-31. PubMed ID: 11298337
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric characterisation of the "false naive" (CD45RA+, CD45RO-, CD29 bright+) peripheral blood T-lymphocytes in health and in rheumatoid arthritis.
Neidhart M; Pataki F; Schönbächler J; Brühlmann P
Rheumatol Int; 1996; 16(2):77-87. PubMed ID: 8853229
[TBL] [Abstract][Full Text] [Related]
16. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.
Takahashi T; Kuniyasu Y; Toda M; Sakaguchi N; Itoh M; Iwata M; Shimizu J; Sakaguchi S
Int Immunol; 1998 Dec; 10(12):1969-80. PubMed ID: 9885918
[TBL] [Abstract][Full Text] [Related]
17. The 4-1BB costimulation augments the proliferation of CD4+CD25+ regulatory T cells.
Zheng G; Wang B; Chen A
J Immunol; 2004 Aug; 173(4):2428-34. PubMed ID: 15294956
[TBL] [Abstract][Full Text] [Related]
18. A novel costimulation pathway via the 4C8 antigen for the induction of CD4+ regulatory T cells.
Masuyama J; Kaga S; Kano S; Minota S
J Immunol; 2002 Oct; 169(7):3710-6. PubMed ID: 12244164
[TBL] [Abstract][Full Text] [Related]
19. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
20. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
